CRPV genomes with synonymous codon optimizations in the CRPV E7 gene show phenotypic differences in growth and altered immunity upon E7 vaccination

PLoS ONE

Volumn 3, Issue 8, 2008, Pages

  Cladel, Nancy M ^a,b   Hu, Jiafen ^a,b   Balogh, Karla K ^a,b   Christensen, Neil D ^a,b  

^a PENN STATE CANCER INSTITUTE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN E7; RNA; MESSENGER RNA; ONCOPROTEIN; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CODON; CONTROLLED STUDY; COTTONTAIL RABBIT PAPILLOMA VIRUS; FLOW CYTOMETRY; HOST; IMMUNIZATION; IMMUNOGENICITY; IMMUNOPRECIPITATION; NONHUMAN; NORTHERN BLOTTING; ONCOGENE; PAPILLOMA; PAPILLOMA VIRUS; PHENOTYPE; PROTECTION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR GROWTH; VACCINATION; VIRUS GENE; VIRUS GENOME; VIRUS IMMUNITY; WILD TYPE; ANIMAL; ANIMAL DISEASE; BIOSYNTHESIS; COTTONTAIL RABBIT PAPILLOMAVIRUS; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; VIROLOGY; VIRUS INFECTION;

COTTONTAIL RABBIT PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

ANIMALS; CODON; COTTONTAIL RABBIT PAPILLOMAVIRUS; FEMALE; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PHENOTYPE; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; VACCINATION; VIRAL PROTEINS;

EID: 51449085986     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002947     Document Type: Article

References (43)

1. Shackelton LA, Parrish CR, Holmes EC (2006) Evolutionary basis of codon usage and nucleotide composition bias in vertebrate DNA viruses. J. Mol. Evol. 62: 551-563.
2. Zhou J, Liu WJ, Peng SW, Sun XY, Frazer I (1999) Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. Journal of Virology 73: 4972-4982.
3. Tindle RW (2002) Immune evasion in human papillomavirus-associated cervical cancer. Nature Rev.Cancer 2: 59-65.
4. Parmley JL, Hurst LD (2007) How do synonymous mutations affect fitness? Bioessays 29: 515-519.
5. Chamary JV, Parmley JL, Hurst LD (2006) Hearing silence: non-neutral evolution at synonymous sites in mammals. Nat.Rev.Genet. 7: 98-108.
6. Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM (2007) The sounds of silence: synonymous mutations affect function. Pharmacogenomics 8: 527-532.
7. Lemm I, Ross J (2002) Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant. Molecular and Cellular Biology 22: 3959-3969.
8. Lavner Y, Kotlar D (2005) Codon bias as a factor in regulating expression via translation rate in the human genome. Gene 345: 127-138.
9. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, et al. (2007) A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315: 525-528.
10. Komar AA, Lesnik T, Reiss C (1999) Synonymous codon substitutions affect ribosome traffic and protein folding during in vitro translation. Febs Letters 462: 387-391.
11. Cortazzo P, Cervenansky C, Marin M, Reiss C, Ehrlich R, et al. (2002) Silent mutations affect in vivo protein folding in Escherichia coli. Biochemical and Biophysical Research Communications 293: 537-541.
12. Segal E, Fondufe-Mittendorf Y, Chen LY, Thastrom A, Field Y, et al. (2006) A genomic code for nucleosome positioning. Nature 442: 772-778.
13. Zhao KN, Gu W, Fang NX, Saunders NA, Frazer IH (2005) Gene codon composition determines differentiation-dependent expression of a viral capsid gene in keratinocytes in vitro and in vivo. Mol.Cell Biol. 25: 8643-8655.
14. Gu W, Ding J, Wang X, de Kluyver RL, Saunders NA, et al. (2007) Generalized substitution or isoencoding codons shortens the duration of papillomavirus L1 protein expression in transiently gene-transfected keratinocytes due to cell differentiation. Nucleic Acids Res. 35: 4820-4832.
15. Gu W, Li M, Zhao WM, Fang NX, Bu S, et al. (2004) tRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes. Nucleic Acids Res. 32: 4448-4461.
16. Capon F, Allen MH, Ameen M, Burden AD, Tillman D, et al. (2004) A synonymous SNP of the corneodesmosin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups. Human Molecular Genetics 13: 2361-2368.
17. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, et al. (2006) Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structine. Science 314: 1930-1933.
18. Duan JB, Wainwright MS, Comeron JM, Saitou N, Sanders AR, et al. (2003) Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Human Molecular Genetics 12: 205-216.
19. Duan JB, Antezana MA (2003) Mammalian mutation pressure, synonymous codon choice, and mRNA degradation. Journal of Molecular Evolution 57: 694-701.
20. Shabalina SA, Ogurtsov AY, Spiridonov NA (2006) A periodic pattern of mRNA secondary structure created by the genetic code. Nucleic Acids Research 34 (8): 2428-2437.
21. Chamary JV, Hurst LD (2005) Evidence for selection on synonymous mutations affecting stability of mRNA secondary structure in mammals. Genome Biology 6 (9).
22. Fairbrother WG, Holste D, Burge CB, Sharp PA (2004) Single nucleotide polymorphism-based validation of exonic splicing enhancer. Plos Biology 2 (9): 1388-1395.
23. Carlini DB (2004) Experimental reduction of codon bias in the Drosophila alcohol dehydrogenase gene results in decreased ethanol tolerance of adult flies. Journal of Evolutionary Biology 17: 779-785.
24. Mueller S, Papamichail D, Coleman JR, Skiena S, Wimmer E (2006) Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity. Journal of Virology 80: 9687-9696.
25. Burns CC, Shaw J, Campagnoli R, Jorba J, Vincent A, et al. (2006) Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region. Journal of Virology 80: 3259-3272.
26. Han RC, Cladel NM, Reed CA, Peng XW, Christensen ND (1999) Protection of rabbits from viral challenge by gene gun-based intracutaneous vaccination with a combination of cottontail rabbit papillomavirus E1, E2, E6, and E7 genes. Journal of Virology 73: 7039-7043.
27. Leachman SA, Shylankevich M, Slade MD, Levine D, Sundaram RK, et al. (2002) Ubiquitin-fused and/or multiple early genes from cottontail rabbit papillomavirus as DNA vaccines. J.Virol. 76: 7616-7624.
28. Han R, Cladel NM, Reed CA, Peng X, Budgeon LR (2000) DNA vaccination prevents and/or delays carcinoma development of papillomavirus-induced skin papillomas on rabbits. J.Virol. 74: 9712-9716.
29. Chen L, Thomas-EK, Hu S.-L, Hellstrom I, Hellstrom KE (1999) Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc.Natl.Acad.Sci.USA 88: 110-114.
30. Kim TG, Kim CH, Won EH, Bae SM, Ahn WS, et al. (2004) CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model 543. Immunology 112 (1): 117-125.
31. Hallez S, Simon P, Maudoux F, Doyen J, Noel JC, et al. (2004) Phase 1/11 trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia. Cancer Immunol.Immunother. 53 (7): 642-650.
32. Liu WJ, Gao F, Zhao KN, Zhao W, Fernando GJ, et al. (2002) Codon. modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity. Virology 301 (1): 43-52.
33. Cid-Arregui, Juarez AV, zur Hausen H (2003) A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein mammalian cells and is useful for DNA immunization studies. Journal of Virology 77 (8): 4928-4937.
34. Samorski RGissmann, W. Osen W (2006) Codon optimized expression of HPV 16 E6 renders target cells susceptible to E6-specific CTL recognition Immunology Letters 107 (1): 41-49.
35. Wang WY, Malcolm BA (1999) Two-stage PCR protocol allowing introduction of multiple mutations, deletions and insertions using QuikChange (TM) site-directed mutagenesis. Biotechniques 26: 680-682.
36. Hu J, Peng Y, Schell TD, Budgeon LR, Cladel NM, et al. (2006) An HLA-A2.1-Transgenic Rabbit Model to Study Immunity to Papillomavirus Infection. J.Immunol. 177: 8037-8045.
37. Embers ME, Budgeon LR, Pickel M, Christensen ND (2002) Protective immunity to rabbit oral and cutaneous papillomaviruses by immunization with short peptides of 12, the minor capsid protein. J.Virol. 76: 9798-9805.
38. Hu J, Han R, Cladel NM, Pickel MD, Christensen ND (2002) Intracutaneous DNA vaccination with the E8 gene of cottontail rabbit papillomavirus induces protective immunity against virus challenge in rabbits. J.Virol. 76: 6453-6459.
39. Hu J, Cladel NM, Balogh K, Budgenn L, Christensen ND (2007) Impact of genetic changes to the CRPV genome and their application to the study of pathogenesis in vivo. Virology 358: 384-390.
40. Zhao KN, Liu WJ, Frazer IH (2003) Codon usage bias and A+T content variation in human papillomavirus genomes. Vinis Res. 98: 95-104.
41. Mossadegh N, Gissmann L, Muller M, Zenigraf H, Alonso A, et al. (2004) Codon optimization of the human papillomavirus 11(HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells. Virology 326: 57-66.
42. Gao F, Li Y, Decker JM, Peyer FW, Bibollet-Ruche F, et al. (2003) Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice AIDS Res.Hum. Retroviruses 19: 817-823.
43. Alunni-Fabbroni M, Littlewood T, Deleu L, Caldeira S, Giarre M, et al. (2000) Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts. Oncogene 19: 2277-2285.